Alzheimer Disease (AD): Clinical Trials

56 trials for Alzheimer Disease (AD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 not yet recruiting, 16 recruiting, 11 completed, 4 enrolling by invitation. 20 Not applicable, 8 Phase 2, 7 Phase 1, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable20Not yet recruiting 8, Completed 4, Recruiting 4, Enrolling by invitation 2, Active not recruiting 1, Terminated 1
Phase 28Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Completed 1, Enrolling by invitation 1
Phase 17Completed 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1
Phase 32Not yet recruiting 1, Recruiting 1
Early Phase 11Recruiting 1

Follow Alzheimer Disease (AD): new trials by email Literature Review of Alzheimer Disease (AD) trials Research Report on Alzheimer Disease (AD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Predicting Pre-dementia
Mild Cognitive Impairment (MCI), Alzheimer Dementia (AD)
RecruitingPrevention Research Consortium Corp.1002026-11-152026-09-22
Exercise in Alzheimer's Disease: Functional Biomarkers
High load, Moderate load, Healthy adults - High load - Alzheimer's Dementia (AD), Alzheimer Disease (AD)
Not applicableNot yet recruitingEuropean University Miguel de Cervantes482026-11-102026-11-05
Remote Digital Assessments for Cognitive Disorders
Mild Cognitive Impairment (MCI), Alzheimer Disease (AD)
Not yet recruitingCentre for Addiction and Mental Health602026-11-012026-10-20
Intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer
Multimodal intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer - Alzheimer Disease (AD), Unwanted Loneliness
Not applicableNot yet recruitingUniversity of Valencia502026-10-012026-06-15
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
DUVAX 200 µg, DUVAX 400 µg, Placebo (Adjuvant only) - Alzheimer Disease, Alzheimer Disease (AD)
Phase 1RecruitingNuravax, Inc.242026-09-252026-09-30
Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training in Alzheimer's Disease
Transcranial Alternating Current Stimulation, Sham Transcranial Alternating Current Stimulation, Individualized Computerized Memory Training - Transcranial Alternating Current Stimulation, Alzheimer Disease (AD)
Not applicableRecruitingIRCCS Centro San Giovanni di Dio Fatebenefratelli302026-09-162026-11-05
Assessment of Changes in Autonomy Through Analysis of Smartphone Usage Data in Patients With Alzheimer's Disease
Data collection, Neuropsychological assesment, Autonomy questionnaire - Alzheimer Disease (AD)
Not yet recruitingPoitiers University Hospital1002026-09-012026-09-18
N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease
Nicotinamide Riboside (NR), Palacebo - Alzheimer Disease (AD)
Phase 2RecruitingHaukeland University Hospital2702026-08-262026-08-20
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers
Education - Mild Cognitive Impairment (MCI), Alzheimer Disease (AD)
Not applicableEnrolling by invitationScripps Translational Science Institute12002026-08-062026-10-14
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
Metronome - Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Not applicableRecruitingBoston University Charles River Campus402026-06-012026-08-13
Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain
tributyrin, Placebo - Alzheimer Disease (AD)
Phase 3Not yet recruitingUniversidad de Almeria1562026-06-012025-12-18
[18F]F-AraG PET Imaging in Alzheimer's Disease
Drug: [18F]F-AraG (PET tracer) - Alzheimer Disease (AD)
Phase 2Not yet recruitingCellSight Technologies, Inc.102026-05-162026-05-28
A Study Testing Whether Low-Dose Radiation Could Help the Immune System and Possibly Improve Early-Onset Alzheimer's Disease.
Low-Dose Whole-Brain Radiotherapy, Control Condition (No Radiotherapy) - Alzheimer Disease (AD), Early Onset Alzheimer Disease
Not applicableNot yet recruitingHeinrich-Heine University, Duesseldorf502026-05-152026-05-04
The Co-Production and Evaluation of the Computerised Cognitive Assessment for Preclinical Alzheimer's Disease (CoCoA-PAD)
Alzheimer Disease (AD)
RecruitingUniversity of Plymouth1202026-05-052026-05-20
Improving Dementia Care in Primary Practice
Improving Dementia Care, Enhanced Usual Care - Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Not applicableNot yet recruitingThomas Jefferson University802026-05-042026-04-17
Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease
Neural Stem Cell-Derived Exosomes - Alzheimer Disease (AD)
Phase 1Not yet recruitingShanghai Mental Health Center92026-05-012026-05-15
Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
Lecanemab 10 mg/kg, Lecanemab 5-10mg/kg - Alzheimer Disease (AD), Alzheimer Dementia
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1402026-04-302026-04-01
Brain NAD in Alzheimer's Disease
Alzheimer Disease (AD)
RecruitingFlorida Atlantic University202026-03-182026-03-24
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease
Cerebrospinal Fluid Flow Cytometry - Ischemic Stroke, Alzheimer Disease (AD)
CompletedCapital Medical University402026-03-012026-09-09
Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease
Alzheimer Disease (AD)
Not yet recruitingIRCCS San Raffaele352026-03-012026-02-24

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (56)  ·  Cognitive Dysfunction (26)  ·  Dementia (13)  ·  Parkinson Disease (4)  ·  Amyotrophic Lateral Sclerosis (3)  ·  Depression (3)  ·  Disease (3)  ·  Lewy Body Disease (3)  ·  Constipation (2)  ·  Frontotemporal Lobar Degeneration (2)  ·  Multiple Sclerosis (2)  ·  Acne Vulgaris (1)  ·  Anxiety Disorders (1)  ·  Arthritis, Rheumatoid (1)  ·  Asthenia (1)

Broader conditions

Brain Diseases (56)  ·  Central Nervous System Diseases (56)  ·  Mental Disorders (56)  ·  Nervous System Diseases (56)  ·  Neurocognitive Disorders (56)  ·  Neurodegenerative Diseases (56)  ·  Tauopathies (55)  ·  Dementia (43)  ·  Cognition Disorders (26)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Nutritional and Metabolic Diseases (7)  ·  Pathologic Processes (7)  ·  Signs and Symptoms (7)  ·  Basal Ganglia Diseases (6)  ·  Metabolic Diseases (6)

Interventions

Transcranial Direct Current Stimulation (2)  ·  lecanemab (2)  ·  ((18)F)PI-2620 (1)  ·  (18F)GTP1 (1)  ·  4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (1)  ·  Amyloid beta-Protein Precursor (1)  ·  Calcium (1)  ·  Data Collection (1)  ·  Dronabinol (1)  ·  Educational Status (1)  ·  Galantamine (1)  ·  Genistein (1)  ·  Ginkgo biloba extract (1)  ·  Levetiracetam (1)  ·  Pharmaceutical Preparations (1)

Sponsors

Nuravax, Inc. (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Abant Izzet Baysal University (1)  ·  Amoneta Diagnostics SAS (1)  ·  Anhui Provincial Hospital (1)  ·  Ashvattha Therapeutics, Inc. (1)  ·  Beijing Municipal Administration of Hospitals (1)  ·  Boston University Charles River Campus (1)  ·  Brigham and Women's Hospital (1)  ·  Capital Medical University (1)  ·  CellSight Technologies, Inc. (1)  ·  Centre for Addiction and Mental Health (1)  ·  Douglas Mental Health University Institute (1)  ·  Eli Lilly and Company (1)  ·  Erasme University Hospital (1)

Countries

United States (16)  ·  China (7)  ·  Spain (5)  ·  Canada (4)  ·  Italy (4)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Brazil (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)

Top investigators

Roman Kniazev (2)  ·  Adrian Ivanoiu, MD (1)  ·  Anahit Ghochikyan, PhD (1)  ·  Audrey Gabelle, MD (1)  ·  Barry Rovner, MD (1)  ·  Bruno Dubois, MD (1)  ·  Caroline Williams-Gray, Dr. (1)  ·  Corinne Lasmezas, PhD (1)  ·  David Cribbs, PhD (1)  ·  Eloi Magnin, MD (1)  ·  Eric J Topol, MD (1)

Results publications

PMID 33017671, PMID 35483736, PMID 37310119, PMID 38386949, PMID 39595863, PMID 41975901, PMID 42248874

NIH funding

R44AG091903 (1), U24AG084436 (1)